| UniProt ID | CDK18_HUMAN | |
|---|---|---|
| UniProt AC | Q07002 | |
| Protein Name | Cyclin-dependent kinase 18 | |
| Gene Name | CDK18 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 474 | |
| Subcellular Localization | ||
| Protein Description | May play a role in signal transduction cascades in terminally differentiated cells.. | |
| Protein Sequence | MIMNKMKNFKRRFSLSVPRTETIEESLAEFTEQFNQLHNRRNENLQLGPLGRDPPQECSTFSPTDSGEEPGQLSPGVQFQRRQNQRRFSMEDVSKRLSLPMDIRLPQEFLQKLQMESPDLPKPLSRMSRRASLSDIGFGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDLIHTDRSLTLVFEYLDSDLKQYLDHCGNLMSMHNVKIFMFQLLRGLAYCHHRKILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIHYEMATGRPLFPGSTVKEELHLIFRLLGTPTEETWPGVTAFSEFRTYSFPCYLPQPLINHAPRLDTDGIHLLSSLLLYESKSRMSAEAALSHSYFRSLGERVHQLEDTASIFSLKEIQLQKDPGYRGLAFQQPGRGKNRRQSIF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 12 | Phosphorylation | KMKNFKRRFSLSVPR HCCCCHHHHCCCCCC | 20.23 | 30266825 | |
| 14 | Phosphorylation | KNFKRRFSLSVPRTE CCCHHHHCCCCCCCH | 28.95 | 23927012 | |
| 20 | Phosphorylation | FSLSVPRTETIEESL HCCCCCCCHHHHHHH | 32.83 | 28348404 | |
| 57 | Phosphorylation | LGRDPPQECSTFSPT CCCCCCCCCCCCCCC | 31.56 | 23927012 | |
| 58 | Phosphorylation | GRDPPQECSTFSPTD CCCCCCCCCCCCCCC | 39.53 | 28857561 | |
| 60 | Phosphorylation | DPPQECSTFSPTDSG CCCCCCCCCCCCCCC | 27.29 | 18691976 | |
| 62 | Phosphorylation | PQECSTFSPTDSGEE CCCCCCCCCCCCCCC | 41.41 | 18691976 | |
| 64 | Phosphorylation | ECSTFSPTDSGEEPG CCCCCCCCCCCCCCC | 51.05 | 23927012 | |
| 72 | Phosphorylation | DSGEEPGQLSPGVQF CCCCCCCCCCCCHHH | 16.24 | 30278072 | |
| 74 | Phosphorylation | GEEPGQLSPGVQFQR CCCCCCCCCCHHHHH | 23.60 | 19369195 | |
| 87 | Phosphorylation | QRRQNQRRFSMEDVS HHHHHCCCCCHHHHH | 21.32 | 23401153 | |
| 89 | Phosphorylation | RQNQRRFSMEDVSKR HHHCCCCCHHHHHHH | 54.80 | 18691976 | |
| 89 (in isoform 3) | Phosphorylation | - | 54.80 | 28978645 | |
| 92 | Phosphorylation | QRRFSMEDVSKRLSL CCCCCHHHHHHHHCC | 25.12 | 23927012 | |
| 93 | Acetylation | RRFSMEDVSKRLSLP CCCCHHHHHHHHCCC | 58.15 | - | |
| 95 (in isoform 3) | Phosphorylation | - | 7.68 | 22210691 | |
| 96 | Phosphorylation | SMEDVSKRLSLPMDI CHHHHHHHHCCCCCC | 34.16 | 30266825 | |
| 98 | Phosphorylation | EDVSKRLSLPMDIRL HHHHHHHCCCCCCCC | 18.28 | 19369195 | |
| 115 | Phosphorylation | EFLQKLQMESPDLPK HHHHHHHHCCCCCCC | 20.55 | 28355574 | |
| 117 | Phosphorylation | LQKLQMESPDLPKPL HHHHHHCCCCCCCCH | 82.16 | 19369195 | |
| 123 | Phosphorylation | ESPDLPKPLSRMSRR CCCCCCCCHHHHHHH | 34.17 | 23927012 | |
| 126 | Phosphorylation | DLPKPLSRMSRRASL CCCCCHHHHHHHHCH | 19.94 | 29514088 | |
| 128 (in isoform 3) | Phosphorylation | - | 22.63 | 18691976 | |
| 128 | Phosphorylation | PKPLSRMSRRASLSD CCCHHHHHHHHCHHH | 22.63 | 18691976 | |
| 130 | Phosphorylation | PLSRMSRRASLSDIG CHHHHHHHHCHHHCC | 26.96 | 29255136 | |
| 132 | Phosphorylation | SRMSRRASLSDIGFG HHHHHHHCHHHCCCC | 25.37 | 22167270 | |
| 134 | Phosphorylation | MSRRASLSDIGFGKL HHHHHCHHHCCCCHH | 4.41 | 18669648 | |
| 141 | Phosphorylation | SDIGFGKLETYVKLD HHCCCCHHHEEEEEE | 44.01 | 23927012 | |
| 142 | Phosphorylation | DIGFGKLETYVKLDK HCCCCHHHEEEEEEE | 6.04 | 23927012 | |
| 144 | Ubiquitination | GFGKLETYVKLDKLG CCCHHHEEEEEEECC | 40.32 | 2189047 | |
| 146 (in isoform 2) | Ubiquitination | - | 38.11 | 21890473 | |
| 147 | Phosphorylation | KLETYVKLDKLGEGT HHHEEEEEEECCCCE | 69.68 | 18691976 | |
| 152 | Phosphorylation | VKLDKLGEGTYATVF EEEEECCCCEEEEEE | 12.99 | 17192257 | |
| 153 | Phosphorylation | KLDKLGEGTYATVFK EEEECCCCEEEEEEE | 15.90 | 23927012 | |
| 155 | Phosphorylation | DKLGEGTYATVFKGR EECCCCEEEEEEECC | 18.96 | 27273156 | |
| 157 | Phosphorylation | LGEGTYATVFKGRSK CCCCEEEEEEECCCH | 6.36 | 18691976 | |
| 162 | Phosphorylation | YATVFKGRSKLTENL EEEEEECCCHHHHHH | 59.05 | 20068231 | |
| 164 | Phosphorylation | TVFKGRSKLTENLVA EEEECCCHHHHHHHH | 26.94 | 17924679 | |
| 171 | Ubiquitination | KLTENLVALKEIRLE HHHHHHHHHHHHHCC | 41.16 | - | |
| 173 (in isoform 2) | Ubiquitination | - | 6.11 | 21890473 | |
| 176 (in isoform 3) | Ubiquitination | - | 39.13 | 21890473 | |
| 184 | Phosphorylation | LEHEEGAPCTAIREV CCCCCCCCCCHHHHH | 24.86 | 28857561 | |
| 185 | Phosphorylation | EHEEGAPCTAIREVS CCCCCCCCCHHHHHH | 12.93 | 18691976 | |
| 187 | Phosphorylation | EEGAPCTAIREVSLL CCCCCCCHHHHHHHH | 35.48 | 18691976 | |
| 190 | Phosphorylation | APCTAIREVSLLKNL CCCCHHHHHHHHHCC | 24.19 | 24719451 | |
| 203 (in isoform 3) | Ubiquitination | - | 1.73 | 21890473 | |
| 278 | Ubiquitination | LLINERGELKLADFG EEECCCCCEEEHHHC | 37.01 | - | |
| 280 (in isoform 2) | Ubiquitination | - | 14.43 | 21890473 | |
| 289 | Phosphorylation | ADFGLARAKSVPTKT HHHCCCCCCCCCCCC | 32.14 | 26074081 | |
| 292 | Phosphorylation | GLARAKSVPTKTYSN CCCCCCCCCCCCCCC | 33.59 | 26074081 | |
| 294 | Phosphorylation | ARAKSVPTKTYSNEV CCCCCCCCCCCCCCE | 34.36 | 26074081 | |
| 295 | Phosphorylation | RAKSVPTKTYSNEVV CCCCCCCCCCCCCEE | 15.85 | 26074081 | |
| 296 | Phosphorylation | AKSVPTKTYSNEVVT CCCCCCCCCCCCEEE | 31.57 | 26074081 | |
| 304 | Phosphorylation | YSNEVVTLWYRPPDV CCCCEEEEEECCCCE | 19.16 | 22817900 | |
| 310 (in isoform 3) | Ubiquitination | - | 6.13 | 21890473 | |
| 376 | Phosphorylation | TAFSEFRTYSFPCYL EECCCCEEECCCEEC | 23.31 | 28857561 | |
| 410 | Phosphorylation | SSLLLYESKSRMSAE HHHHHHCCCCCCCHH | 42.36 | 30206219 | |
| 413 | Phosphorylation | LLYESKSRMSAEAAL HHHCCCCCCCHHHHH | 23.11 | 30206219 | |
| 419 | Phosphorylation | SRMSAEAALSHSYFR CCCCHHHHHCHHHHH | 12.98 | 30206219 | |
| 421 | Phosphorylation | MSAEAALSHSYFRSL CCHHHHHCHHHHHHH | 23.69 | 28857561 | |
| 422 | Phosphorylation | SAEAALSHSYFRSLG CHHHHHCHHHHHHHH | 9.51 | 30206219 | |
| 425 | Phosphorylation | AALSHSYFRSLGERV HHHCHHHHHHHHHHH | 30.72 | 30206219 | |
| 436 | Phosphorylation | GERVHQLEDTASIFS HHHHHHHHHHHHEEE | 16.96 | 28857561 | |
| 438 | Phosphorylation | RVHQLEDTASIFSLK HHHHHHHHHHEEEEE | 26.68 | 28857561 | |
| 440 | Phosphorylation | HQLEDTASIFSLKEI HHHHHHHHEEEEEEE | 6.92 | - | |
| 441 | Phosphorylation | QLEDTASIFSLKEIQ HHHHHHHEEEEEEEE | 36.54 | 20873877 | |
| 443 | Phosphorylation | EDTASIFSLKEIQLQ HHHHHEEEEEEEECC | 52.12 | - | |
| 463 | Methylation | RGLAFQQPGRGKNRR CCCCCCCCCCCCCCC | 60.64 | - | |
| 470 | Phosphorylation | PGRGKNRRQSIF--- CCCCCCCCCCCC--- | 24.93 | 17192257 | |
| 472 | Phosphorylation | RGKNRRQSIF----- CCCCCCCCCC----- | 11.24 | 18691976 | |
| 502 | Phosphorylation | ----------------------------------- ----------------------------------- | 18691976 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CDK18_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CDK18_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CDK18_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-14; SER-57;SER-72; SER-87; SER-96; SER-115; SER-130 AND THR-141, PHOSPHORYLATION[LARGE SCALE ANALYSIS] AT SER-89 (ISOFORM 3), AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-87 AND SER-130,AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-72; SER-87;SER-96; SER-115; SER-130; THR-155 AND SER-470, AND MASS SPECTROMETRY. | |
| "Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry."; Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.; Mol. Cell. Proteomics 6:537-547(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-87 AND SER-130,AND MASS SPECTROMETRY. | |